Results 141 to 150 of about 715,082 (295)

Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma

Modern Pathology, 2017
O. Basturk, M. Berger, H. Yamaguchi, V. Adsay, G. Askan, U. Bhanot, A. Zehir, F. Carneiro, Seung‐Mo Hong, G. Zamboni, E. Dikoglu, V. Jobanputra, K. Wrzeszczynski, Serdar Balci, P. Allen, Naoki Ikari, S. Takeuchi, H. Akagawa, A. Kanno, T. Shimosegawa, T. Morikawa, F. Motoi, M. Unno, R. Higuchi, Masakazu Yamamoto, K. Shimizu, T. Furukawa, D. Klimstra   +27 more
semanticscholar   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

Artificial intelligence networks for assessing the prognosis of gastrointestinal cancer to immunotherapy based on genetic mutation features: a systematic review and meta-analysis. [PDF]

BMC Gastroenterol
Norouzkhani N, Mobaraki H, Varmazyar S, Zaboli H, Mohamadi Z, Nikeghbali G, Bagheri K, Marivany N, Najafi M, Nozad Varjovi M, Abouzeid M, Zeidi Baghrabad H, Eini P, Azhdarimoghaddam A, Khosravi F, Asadi Anar M.   +15 more
europepmc   +1 more source

On the Use of Radon in the Treatment of Neoplasms of the Skin [PDF]

, 1930
R. T. Brain
openalex   +1 more source

The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN)

Cancer, 2016
M. McMillan, Russell S. Lewis, J. Drebin, U. Teitelbaum, M. K. Lee, R. Roses, D. Fraker, C. Vollmer   +7 more
semanticscholar   +1 more source

TRPM8 levels determine tumor vulnerability to channel agonists

Molecular Oncology, EarlyView.
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo, Francesco Giuseppe Carbone, Kristi Buzo, Nicole Annesi, Sacha Genovesi, Annalisa Lorenzato, Karen Widmann, Michela Libergoli, Elisa Marmocchi, Giovanni Bertalot, Alberto Brolese, Mauro Giulio Papotti, Luca Molinaro, Orazio Caffo, Mattia Barbareschi, Alberto Bardelli, Alessandro Romanel, Sabrina Arena, Andrea Lunardi   +18 more
wiley   +1 more source

An early-detected intraductal papillary squamous neoplasm of the pancreas under peroral pancreatoscopy. [PDF]

Endoscopy
Shen S, Nie S, Wang L.
europepmc   +1 more source

Advanced Osteo-Arthropathy in a Case of Pulmonary Neoplasm [PDF]

, 1930
Harold Avery
openalex   +1 more source

The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes

Modern Pathology, 2016
O. Basturk, M. Tan, U. Bhanot, P. Allen, V. Adsay, Sasinya N. Scott, Ronak H. Shah, M. Berger, G. Askan, E. Dikoglu, V. Jobanputra, K. Wrzeszczynski, C. Sigel, C. Iacobuzio-Donahue, D. Klimstra   +14 more
semanticscholar   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

Molecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Emilie Brotin, Mélanie Briand, Enora Dolivet, Laurent Poulain, Marie Villedieu   +10 more
wiley   +1 more source